Sopharma AD (SPH) — Cash Flow-to-Debt Ratio
Sopharma AD (SPH) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2025, meaning its operating cash flow of zł-17.24 Million could theoretically repay 0% of its total liabilities (zł1.05 Billion) in one year. See cash generation quality of Sopharma AD to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sopharma AD Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Sopharma AD across 14 annual periods. Also explore net asset growth rate of Sopharma AD to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sopharma AD (2011–2024)
Year-by-year debt coverage analysis for Sopharma AD. For market capitalisation and broader financial context, see SPH market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (PLN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.08x | zł76.73 Million | zł953.18 Million | ▲ +35.9% |
| 2023 | 0.06x | zł45.03 Million | zł760.54 Million | ▼ -74.5% |
| 2022 | 0.23x | zł124.62 Million | zł537.67 Million | ▲ +266.6% |
| 2021 | -0.14x | zł-75.96 Million | zł546.11 Million | ▲ +47.6% |
| 2020 | -0.27x | zł-179.41 Million | zł675.52 Million | ▼ -24.0% |
| 2019 | -0.21x | zł-128.44 Million | zł599.50 Million | ▼ -479.5% |
| 2018 | 0.06x | zł28.34 Million | zł502.07 Million | ▼ -32.6% |
| 2017 | 0.08x | zł40.00 Million | zł477.62 Million | ▼ -39.1% |
| 2016 | 0.14x | zł50.64 Million | zł368.00 Million | ▲ +144.0% |
| 2015 | 0.06x | zł21.31 Million | zł377.99 Million | ▲ +7.8% |
| 2014 | 0.05x | zł20.18 Million | zł385.73 Million | ▼ -33.8% |
| 2013 | 0.08x | zł29.25 Million | zł370.01 Million | ▼ -20.5% |
| 2012 | 0.10x | zł35.20 Million | zł354.06 Million | ▼ -19.6% |
| 2011 | 0.12x | zł38.40 Million | zł310.78 Million | — |